Research

Mingjiang Xu, PhD holds a pipette, concentrating on a sample in a laboratory filled with scientific equipment.

Cracking cancer’s code: New research identifies novel drug target for acute myeloid leukemia treatment

June 23, 2026

By Claire Kowalick Despite advances in cancer treatment in recent years, five-year survival rates for acute myeloid leukemia (AML) remain low at just 30% on average, according to the National Cancer Institute. Factors in the development of AML are diverse and have many different drivers. A longtime goal for scientists in this field is to […]


A lab technician in a white coat and blue gloves is using a pipette to add liquid to a transparent tube above a black container filled with ice cubes.

Drug-discovery breakthrough for large and polar drugs: Discovery of chemical endocytosis could redefine precision medicine

June 23, 2026

By Claire Kowalick A team of scientists, notably Zhengyu Wang, PhD, assistant professor in the department of pharmacology at The University of Texas at San Antonio and the Barshop Institute, led by Hong-yu Li, PhD, professor of medicinal chemistry and chemical biology with the department of pharmacology and the Barshop Institute, together with two other […]


Daohong Zhou, MD researches in a white lab coat works at a laptop in a laboratory, focused and engaged in his task.

Targeted drug offers hope for safe, effective senolytic treatment for liver disease, cancer

June 23, 2026

By Claire Kowalick San Antonio has one of the highest rates of metabolic dysfunction-associated steatotic liver disease (MASLD) in the United States, largely driven by high rates of obesity and diabetes in the region. This chronic liver condition can lead to serious health conditions including severe liver fibrosis or cirrhosis and liver cancer, posing a […]


Andrew J. Brenner, MD, PhD smiles in a whitecoat in front of a lab.

Drug found to double survival time for glioblastoma patients

June 23, 2026

By Steven Lee A drug developed at The University of Texas at San Antonio has been shown to extend survival for patients with glioblastoma, the most common primary brain tumor in adults. Results of a trial led by the university revealed that a unique investigational drug formulation called Rhenium Obisbemeda (186RNL) more than doubled median […]


Majeet Rao, PhD focuses, while wearing a white lab coat, examines a document in a laboratory filled with shelves of supplies.

Uncovering how some cancers outsmart the immune system

June 23, 2026

By Claire Kowalick For years, scientists have found the overexpression of a specific protein called FOXM1 in a wide range of cancers, including ovarian, breast and pediatric cancers. A recent study by scientists at The University of Texas at San Antonio has now led to understanding its exact role in cancer development and is the […]


Patrick Sung, DPhil, in a white lab coat stands smiling in a busy laboratory filled with equipment and other researchers in the background.

Key DNA complex connected to PARP inhibitor cancer-drug resistance discovered

June 23, 2026

By Claire Kowalick Scientists have made one of the most important discoveries to date in the study and treatment of BRCA1-deficient cancers and drug resistance. Approximately one in 300 Americans have a pathogenic mutation in the BRCA1 or BRCA2 gene, placing them at an elevated risk of developing certain cancers, especially breast and ovarian cancer. […]